Clinical Trials Browser

Phase 2 × INDUSTRY × Vitamin D × Clear all

NCT00396279 2022-11-08

Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone

Phase 2 Completed

37 enrolled 13 charts

Giant Cell Tumor of Bone

NCT00172068 2009-12-23

MRD-1

Phase 2 Terminated

Neoplasm, Residual